These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 3050774)
1. [The effect of vitamin A therapy on the immune function and lipid peroxidation in patients with Sjögren syndrome]. Szöcsik K; Rhenso GC; Cao VV; Mézes M; Szongoth M; Gergely P Orv Hetil; 1988 Sep; 129(39):2091-4. PubMed ID: 3050774 [No Abstract] [Full Text] [Related]
2. Effect of vitamin A treatment on immune reactivity and lipid peroxidation in patients with Sjögren's syndrome. Szöcsik K; González-Cabello R; Vien CV; Mézes M; Szongoth M; Gergely P Clin Rheumatol; 1988 Dec; 7(4):514-9. PubMed ID: 3246135 [TBL] [Abstract][Full Text] [Related]
3. Alternate-day steroid therapy for patients with primary Sjögren's syndrome. Tabbara KF; Frayha RA Ann Ophthalmol; 1983 Apr; 15(4):358-61. PubMed ID: 6660708 [No Abstract] [Full Text] [Related]
4. Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome. Szántó A; Harangi M; Seres I; Paragh G; Zeher M Int Immunol; 2010 Jul; 22(7):605-9. PubMed ID: 20497955 [TBL] [Abstract][Full Text] [Related]
5. [Thymosin in the treatment of Sjogren's syndrome]. Wen ZX Zhonghua Kou Qiang Ke Za Zhi; 1986 Jul; 21(4):219-20, 254. PubMed ID: 3471407 [No Abstract] [Full Text] [Related]
6. [Scleroderma and Gougerot-Sjögren syndrome. Effect of methotrexate therapy]. Welin J; Grolleau JY; Barrière H Sem Hop Ther; 1973 Jan; 49(1):37-41. PubMed ID: 4712023 [No Abstract] [Full Text] [Related]
7. Rituximab therapy in primary Sjögren's syndrome. Alcântara C; Gomes MJ; Ferreira C Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218 [TBL] [Abstract][Full Text] [Related]
8. [Use of physalaemin in the treatment of Sjogren's disease]. Tamborini A; Perrotta P Ann Ottalmol Clin Ocul; 1969 Dec; 95(12):945-60. PubMed ID: 5408524 [No Abstract] [Full Text] [Related]
9. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab. Ahmadi-Simab K; Lamprecht P; Nölle B; Ai M; Gross WL Ann Rheum Dis; 2005 Jul; 64(7):1087-8. PubMed ID: 15958765 [No Abstract] [Full Text] [Related]
10. Sjogren's syndrome. When your tissues dry out. Mayo Clin Health Lett; 2006 Jul; 24(7):7. PubMed ID: 16865802 [No Abstract] [Full Text] [Related]
15. Antibody-dependent cell-mediated cytotoxicity by peripheral blood mononuclear cells from patients with Sjögren's syndrome, with special reference to differentiation from phagocytic activity. Ichikawa Y; Takaya M; Arimori S Tokai J Exp Clin Med; 1980 Jan; 5(1):83-90. PubMed ID: 7385266 [TBL] [Abstract][Full Text] [Related]
16. Reticuloendothelial Fc receptor function in patients with Sjogren's syndrome. O'Sullivan MM; Walker DM; Williams BD Clin Exp Immunol; 1985 Sep; 61(3):483-8. PubMed ID: 4075586 [TBL] [Abstract][Full Text] [Related]
17. [Immunosuppression in Sjogren's syndrome with a pseudo-leukemic lymphocyte reaction]. Orlowski Z; Jedrzejewska T Pol Tyg Lek; 1970 Oct; 25(42):1588-9. PubMed ID: 5476524 [No Abstract] [Full Text] [Related]
18. Relationship between the occurrence of anti-SSA, anti-SSB autoantibodies and HLA class II alleles from the aspect of in vitro inhibitory effect of glucocorticosteroid on the antibody-dependent cellular cytotoxicity in patients with primary Sjögren's syndrome. Kovács A; Szekeres E; Berek L; Endreffy E; Kovács L; Makula E; Eller J; Pokorny G; Petri IB Acta Microbiol Immunol Hung; 2000; 47(4):421-31. PubMed ID: 11056762 [TBL] [Abstract][Full Text] [Related]
19. What is Sjögren's syndrome and why is it important? Talal N J Rheumatol Suppl; 2000 Dec; 61():1-3. PubMed ID: 11128697 [No Abstract] [Full Text] [Related]